ROKIT HEALTHCARE Inc. Logo

ROKIT HEALTHCARE Inc.

Uses 3D bioprinting and AI for autologous organ regeneration to treat chronic conditions.

376900 | KO

Overview

Corporate Details

ISIN(s):
KR7376900007
LEI:
Country:
South Korea
Address:
서울특별시 금천구 디지털로10길 9, 12층, 서울특별시
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

ROKIT HEALTHCARE Inc. is a biotechnology company specializing in hyper-personalized organ regeneration and regenerative medicine. Established in 2012, the company develops and commercializes advanced healthcare solutions centered on its proprietary 3D and 4D bioprinting technologies, specialized bioinks, and AI-driven platforms. Its primary focus is on providing effective treatments for chronic conditions, such as diabetic foot ulcers and skin ailments, by shifting the treatment paradigm from conventional surgery to autologous organ regeneration. The company has secured patents for its innovative multi-organ bioprinting technology, aiming to offer safer and more effective therapeutic options worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-12 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 48.9 KB
2025-09-11 00:00
Pre-Annual General Meeting Information
주주총회소집결의 (임시주주총회)
Korean 6.8 KB
2025-09-11 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정 (임시주주총회)
Korean 4.3 KB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-08-01 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.3 KB
2025-07-18 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 5.6 KB
2025-07-16 00:00
Capital/Financing Update
주요사항보고서(전환사채권발행결정)
Korean 72.0 KB
2025-05-19 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 118.9 KB
2025-05-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-05-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB
2025-05-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB
2025-05-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB
2025-05-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB
2025-05-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB
2025-05-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.9 KB

Automate Your Workflow. Get a real-time feed of all ROKIT HEALTHCARE Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ROKIT HEALTHCARE Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ROKIT HEALTHCARE Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

DG INNOVATE PLC Logo
Develops sustainable tech for EV drivetrains and next-gen energy storage materials.
United Kingdom
DGI
Dianthus Therapeutics, Inc. /DE/ Logo
Developing selective antibody therapies for severe autoimmune diseases.
United States of America
DNTH
Dogwood Therapeutics, Inc. Logo
Developing non-opioid therapeutics for neuropathic pain, fibromyalgia, and cancer-related pain.
United States of America
DWTX
DreamCIS INC. Logo
A CRO providing clinical research services for pharma, biotech, and medical device industries.
South Korea
223250
DT&CRO CO., Ltd. Logo
A full-service CRO for pharma & biotech, from non-clinical studies to FDA approval support.
South Korea
383930
D.Western Therapeutics Institute, Inc. Logo
Biotech firm discovering and licensing drug candidates, focusing on kinase inhibitors.
Japan
4576
Ectin Research AB Logo
Clinical-stage biotech developing novel cancer treatments, focusing on metastatic bladder cancer.
Sweden
ECTIN B
EdgeLab S.p.A. Logo
Specializing in underwater robotics, AUVs, and sensor systems for marine research and heritage.
Italy
ELB
Editas Medicine, Inc. Logo
Developing CRISPR-based genomic medicines to treat serious and rare genetic diseases.
United States of America
EDIT
Eledon Pharmaceuticals, Inc. Logo
Develops immunomodulatory therapies to prevent organ rejection in transplant patients.
United States of America
ELDN

Talk to a Data Expert

Have a question? We'll get back to you promptly.